| Display title | Chemistry:Nicotinic antagonist |
| Default sort key | Nicotinic antagonist |
| Page length (in bytes) | 4,791 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 824520 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Jport |
| Date of page creation | 01:42, 16 March 2024 |
| Latest editor | imported>Jport |
| Date of latest edit | 01:42, 16 March 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | A nicotinic antagonist is a type of anticholinergic drug that inhibits the action of acetylcholine (ACh) at nicotinic acetylcholine receptors. These compounds are mainly used for peripheral muscle paralysis in surgery, the classical agent of this type being tubocurarine, but some centrally acting compounds... |
